Detected ·
Orakl Oncology
€30.6MSeries A
Paris-based AI oncology company Orakl Oncology raised a Series A round of ~€30.6M (~$34M), co-led by Norrsken VC and Singular, to scale its AI-driven virtual patient platform.
- Website
- —
- linkedin.com/company/85957194
- Amount
- €30 600 000 EUR
- Stage
- Series A
- Event
- Funding round
- Detected
- 2026-11-12 14:54:08 UTC
- Signal ID
- 55451dc4-fd0a-4dba-a452-22ddd8f491e9
As the API returns it
{
"id": "55451dc4-fd0a-4dba-a452-22ddd8f491e9",
"created_at": "2026-11-12T14:54:08.423454Z",
"company_name": "Orakl Oncology",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/85957194",
"event_type": "funding",
"funding_amount": 30600000,
"funding_currency": "EUR",
"funding_stage": "series_a",
"message": "*Paris-based AI oncology company Orakl Oncology raised a Series A round of ~€30.6M (~$34M), co-led by Norrsken VC and Singular, to scale its AI-driven virtual patient platform.*"
}